RO.CH

374

-1.16%↓

NOVN.CH

129.72

+0.68%↑

LONN.CH

530

+1.57%↑

RO.CH

374

-1.16%↓

NOVN.CH

129.72

+0.68%↑

LONN.CH

530

+1.57%↑

RO.CH

374

-1.16%↓

NOVN.CH

129.72

+0.68%↑

LONN.CH

530

+1.57%↑

RO.CH

374

-1.16%↓

NOVN.CH

129.72

+0.68%↑

LONN.CH

530

+1.57%↑

RO.CH

374

-1.16%↓

NOVN.CH

129.72

+0.68%↑

LONN.CH

530

+1.57%↑

Search

Straumann Holding AG

Open

SectorGezondheidszorg

91.22 1.15

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

90.18

Max

92.72

Belangrijke statistieken

By Trading Economics

Inkomsten

-117M

119M

Verkoop

-91M

1.3B

K/W

Sectorgemiddelde

33.903

108.767

Dividendrendement

1.09

Winstmarge

9.506

Werknemers

11,319

EBITDA

384M

818M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+7.42% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.09%

2.21%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-794M

15B

Vorige openingsprijs

90.07

Vorige sluitingsprijs

91.22

Nieuwssentiment

By Acuity

50%

50%

167 / 351 Rangschikking in Healthcare

Straumann Holding AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 apr 2025, 08:20 UTC

Marktinformatie

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Peer Vergelijking

Prijswijziging

Straumann Holding AG Prognose

Koersdoel

By TipRanks

7.42% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 97.6 CHF  7.42%

Hoogste 114 CHF

Laagste 79 CHF

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Straumann Holding AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

6 ratings

1

Buy

3

Hold

2

Sell

Sentiment

By Acuity

167 / 351 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Straumann Holding AG

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
help-icon Live chat